Bone Marrow Transplantation News

Marcel van den Brink, MD, PhD, has been appointed president of City of Hope Los Angeles and National Medical Center.

When I was young, green and fresh out of school, I got a job as a clinical social worker in an adult bone marrow transplant program.

A pathfinder spaceflight investigation has flown to the International Space Station with a goal of expanding a population of hematopoietic stem cells that retain their multipotency.

Younger patients with diverse gut microbiota prior to allogeneic hematopoietic stem cell transplantation had a significantly lower risk for death following the procedure than those with low diversity, according to study results.

The FDA announced several regulatory actions the past few weeks.

A phase 2 trial of axatilimab for chronic graft-versus-host disease met its primary endpoint, according to the agent’s manufacturer.

Chronic graft-versus-host disease is a major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation.

A man has remained in treatment-free HIV remission for nearly 2 years after receiving a stem-cell transplant to treat a rare and aggressive form of leukemia, researchers reported Wednesday.

For years now, transplant physicians have spoken different languages when referring to a matter of utmost relevance — graft-versus-host disease.

A treosulfan-based reduced-toxicity conditioning regimen has significantly improved hematopoietic cell transplantation outcomes for patients with high-risk thalassemia major and hematologic malignancies.